Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
BörsenkürzelSRDX
Name des UnternehmensSurmodics Inc
IPO-datumMar 04, 1998
CEOHance (Robert B)
Anzahl der mitarbeiter389
WertpapierartOrdinary Share
GeschäftsjahresendeMar 04
Addresse9924 West 74th Street
StadtEDEN PRAIRIE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55344
Telefon19525007000
Websitehttps://www.surmodics.com/
BörsenkürzelSRDX
IPO-datumMar 04, 1998
CEOHance (Robert B)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten